Psyence Biomedical Ltd [NASDAQ: PBM] stock went on a downward path that fall over -2.81% on Tuesday, amounting to a one-week price decrease of less than -27.00%.
Over the last 12 months, PBM stock dropped by -99.40%.
The market cap for the stock reached $3.57 million, with 13.39 million shares outstanding and 9.32 million shares in the current float. Compared to the average trading volume of 5.19M shares, PBM stock reached a trading volume of 37307108 in the most recent trading day, which is why market watchdogs consider the stock to be active.
PBM Stock Performance Analysis:
Psyence Biomedical Ltd [PBM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -27.00. With this latest performance, PBM shares dropped by -38.02% in over the last four-week period, additionally sinking by -93.62% over the last 6 months – not to mention a drop of -99.40% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PBM stock in for the last two-week period is set at 26.42, with the RSI for the last a single of trading hit 23.42, and the three-weeks RSI is set at 28.30 for Psyence Biomedical Ltd [PBM]. The present Moving Average for the last 50 days of trading for this stock 0.1478, while it was recorded at 0.0732 for the last single week of trading.
Insight into Psyence Biomedical Ltd Fundamentals:
Psyence Biomedical Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.01 and a Current Ratio set at 0.01.
